Innogene Kalbiotech – Official Website

Thailand FDA and Myanmar FDBA approved TheraCIM

Nimotuzumab, a new monoclonal antibody against the human EGFR with optimized affinity, was granted marketing authorization approvals in Thailand (November 2010) and in Myanmar (July 2010). The Thailand Food and Drug Authority in November 2010 approved nimotuzumab under the brand name of TheraCIM for the indication of relapsed high-grade glioma in children and adolescents. The Myanmar Food and Drug Board of Authority issued the Drug Registration Certificate with registration number of 1507AA2558 in July 2010. In Myanmar, nimotuzumab is also registered under the brand name of TheraCIM. It is indicated for patients with advanced head and neck ...

Series of Lanzox Events in 2010

Innogene Kalbiotech has once again showed its commercialization skill by introducing its new product “Lanzox”. Lanzox is a highly purified protein that is extracted from bacteria by advanced biotechnology. It is a reversible neuromuscular blocker and thus resulted in local muscle relaxation. Over hundred thousand cases have been treated with Lanzox in 30 countries and the most extensive application of Lanzox is for the treatment muscle spasticity and muscle stiffness in adult and children spasticity cases and movement disorders. The other application is to rejuvenate human skin and skin anti-aging application. Lanzox was presented in ERPOUR clinic ...

Innogene Kalbiotech won “2010 Asia Pacific Frost & Sullivan Emerging Company of the Year in Oncology”

Innogene was named the Emerging Company of the Year in Oncology at the Frost & Sullivan 3rd Annual Asia Pacific Best Practices Awards Ceremony 2010. The Award is conferred to Innogene as an up-and-coming emerging company with a vision that has enabled it to grow despite the significant obstacles facing the company. It recognises the company’s identification of a unique or bold product or service solution with significant market potential and successfully meeting the challenges associated with bringing it to market. [caption id="attachment_179" align="alignnone" width="587" caption="Dr Rikrik Ilyas accepting the Frost and Sullivan Award for Innogene Kalbiotech"][/caption] Dr Rikrik Ilyas, Director, Innogene ...